solid tumor

Prune
Biotech

Pfizer drops another early cancer candidate from Seagen

The decision to scrap the ADC was made for “business reasons” and “was not related to any safety concerns or requests from regulatory authorities.”
Darren Incorvaia Mar 19, 2026 12:56pm
pipeline valve pipe flow water tap

Ono’s Deciphera drops early-stage solid tumor drug

Mar 3, 2026 7:47pm
red tape delay stop error tie down stall

As CAR-T gains ground on solid tumors, red tape blocks progress

Feb 26, 2026 3:08pm
Make a delay and accumulation of outstanding tasks Full stop

Accent halts DHX9 inhibitor trial over adverse events

Feb 26, 2026 5:01am
Cargo shipping containers lost in ocean

Novartis jettisons ph. 1 cancer candidate after 0% efficacy

Feb 19, 2026 2:45pm
reshuffle pipeline target reorganize shift change

Novartis nixes 6 ph. 1 assets, adds 2 new cancer candidates

Feb 4, 2026 12:09pm